What is the maximum dose of baclofen, its common side effects, and its contraindications?

Baclofen Maximum Dose, Side Effects, and Contraindications

Maximum Dose

The usual maximum dose of baclofen is 80 mg/day divided three times daily, though elderly patients rarely tolerate more than 30–40 mg/day. 1

Standard Adult Dosing

• Begin at 5 mg three times daily (15 mg/day total) and increase by 5 mg per dose every 3 days as tolerated 1
• Target maintenance range is 40–80 mg/day divided three times daily 1
• The 80 mg/day maximum is recommended because higher doses markedly increase adverse effects 1
• Three-times-daily administration is required due to baclofen's short half-life 1

Elderly Patient Dosing

• Start at 5 mg three times daily with slower titration intervals (every 5–7 days) 1, 2
• Maximum tolerated dose is typically 30–40 mg/day in older adults 1, 2, 3
• Elderly patients rarely tolerate doses exceeding this range 2, 3

Special Considerations

• Some patients with severe spasticity may require doses exceeding 80 mg/day when oral therapy fails, but this should prompt consideration for intrathecal baclofen rather than escalating oral doses 1
• Doses above 100 mg/day lack reliable safety evaluation due to limited data and study heterogeneity 4
• In renal impairment, dose reduction is necessary because baclofen is primarily excreted unchanged through the kidneys 5

---

Side Effects

Most Common Adverse Effects (Dose-Dependent)

Transient drowsiness is the most common side effect, occurring in 10–63% of patients. 5

• Drowsiness/Sedation: 10–63% (compared to 36% with placebo) 5
• Dizziness: 5–15% 5
• Weakness: 5–15% 5
• Fatigue: 2–4% 5
• Muscle weakness: Dose-dependent, requires monitoring 1, 3

Neuropsychiatric Effects

• Confusion: 1–11% (particularly problematic in elderly) 3, 5
• Headache: 4–8% 5
• Insomnia: 2–7% 5
• Rarely: euphoria, excitement, depression, hallucinations, paresthesia, tremor, ataxia, seizures 5
• Cognitive effects and mental confusion are particularly concerning in elderly patients 3

Cardiovascular Effects

• Hypotension: 0–9% 5
• Rare: dyspnea, palpitation, chest pain, syncope 5

Gastrointestinal Effects

• Nausea: 4–12% 5
• Constipation: 2–6% 5
• Dry mouth: Common with baclofen 4
• Rarely: anorexia, taste disorder, abdominal pain, vomiting, diarrhea 5

Genitourinary Effects

• Urinary frequency: 2–6% 5
• Urinary dysfunction requires monitoring throughout treatment 1
• Rarely: enuresis, urinary retention, dysuria, impotence, inability to ejaculate 5

Other Notable Effects

• Paraesthesia and muscle spasms/rigidity: Increased with baclofen 6
• Rash, pruritus, ankle edema, excessive perspiration, weight gain 5
• Laboratory abnormalities: increased SGOT, elevated alkaline phosphatase, elevated blood sugar 5

---

Contraindications and Critical Warnings

Absolute Contraindications

Baclofen is contraindicated in patients with hypersensitivity to the drug. 5

• Significant renal dysfunction: Baclofen is primarily excreted unchanged through the kidneys and requires dose reduction or avoidance 5
• Significant hepatic dysfunction: Use with extreme caution 2

Life-Threatening Withdrawal Risk

Never discontinue baclofen abruptly—this is the most critical safety concern. 1, 3, 5

• Abrupt withdrawal can cause: hallucinations, seizures, psychiatric symptoms, hyperthermia, CNS irritability, and potentially death 1, 3, 5
• Taper gradually over at least 1–2 weeks when discontinuing 1, 3
• Withdrawal symptoms usually respond to rapid baclofen re-introduction 1

Pregnancy and Neonatal Considerations

• Pregnancy Category C: Baclofen increased omphaloceles in rat fetuses at 13× the maximum human dose 5
• Neonatal withdrawal symptoms have been reported (increased muscle tone, tremor, jitteriness, seizures) in infants whose mothers took baclofen throughout pregnancy 5
• If used during pregnancy, gradually reduce and discontinue before delivery when feasible 5

Special Population Warnings

• Stroke patients: Baclofen has not significantly benefited stroke patients and they show poor tolerability 5
• Elderly patients: High risk of falls, sedation, cognitive impairment, and urinary dysfunction 1, 2, 3
• Frail patients: Avoid in those with mobility deficits, weight loss, weakness, or cognitive deficits 2

Drug Interactions

• Avoid concurrent benzodiazepine use in stroke recovery patients—the combination impairs neurological recovery and increases sedation 1
• CNS depressants (benzodiazepines, opioids, antihistamines) amplify sedative effects and increase respiratory depression risk 1

Monitoring Requirements Throughout Treatment

• Muscle weakness 1, 3
• Urinary function 1, 3
• Cognitive effects 1, 3
• Sedation 1, 3
• Fall risk (especially in elderly) 1, 2